These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3378430)

  • 1. Thiomersal allergy and vaccination reactions.
    Cox NH; Forsyth A
    Contact Dermatitis; 1988 Apr; 18(4):229-33. PubMed ID: 3378430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions to thimerosal in hepatitis B vaccines.
    Rietschel RL; Adams RM
    Dermatol Clin; 1990 Jan; 8(1):161-4. PubMed ID: 2137393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitizing capacity of merthiolate and its methyl analogue.
    Möller H; Trofast J
    J Biol Stand; 1979 Jul; 7(3):153-55. PubMed ID: 500735
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal.
    Audicana MT; Muñoz D; del Pozo MD; Fernández E; Gastaminza G; Fernández de Corres L
    Am J Contact Dermat; 2002 Mar; 13(1):3-9. PubMed ID: 11887097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergy to non-toxoid constituents of vaccines and implications for patch testing.
    Cox NH; Moss C; Forsyth A
    Contact Dermatitis; 1988 Mar; 18(3):143-6. PubMed ID: 3365966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter survey related to the frequency of positive patch tests with mercury and thiomersal].
    Lachapelle JM; Chabeau G; Ducombs G; Lacroix M; Martin P; Reuter G; Marot L
    Ann Dermatol Venereol; 1988; 115(8):793-6. PubMed ID: 2974266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiomersal.
    Wilkinson DS
    Contact Dermatitis; 1979 Jan; 5(1):58-9. PubMed ID: 421465
    [No Abstract]   [Full Text] [Related]  

  • 10. [Source and clinical significance of allergy for thiomersal, an organic mercury compound].
    van 't Veen AJ; van Joost T
    Ned Tijdschr Geneeskd; 1996 Feb; 140(6):297-300. PubMed ID: 8720702
    [No Abstract]   [Full Text] [Related]  

  • 11. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ
    Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of delayed-type and immediate-type hypersensitivity in healthcare workers with hand eczema.
    Ibler KS; Jemec GB; Garvey LH; Agner T
    Contact Dermatitis; 2016 Oct; 75(4):223-9. PubMed ID: 27352907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines without thiomersal: why so necessary, why so long coming?
    van't Veen AJ
    Drugs; 2001; 61(5):565-72. PubMed ID: 11368282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
    Pichichero ME; Cernichiari E; Lopreiato J; Treanor J
    Lancet; 2002 Nov; 360(9347):1737-41. PubMed ID: 12480426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination despite thimerosal sensitivity.
    Aberer W
    Contact Dermatitis; 1991 Jan; 24(1):6-10. PubMed ID: 2044374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
    Bigham M; Copes R
    Drug Saf; 2005; 28(2):89-101. PubMed ID: 15691220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiomersal-containing vaccines - a review of the current state of knowledge.
    Gołoś A; Lutyńska A
    Przegl Epidemiol; 2015; 69(1):59-64, 157-61. PubMed ID: 25862449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant effect of tuberculin in experimental sensitization to merthiolate.
    Magnusson B; Möller H
    Arch Dermatol Res (1975); 1977 May; 258(3):235-9. PubMed ID: 583641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiomersal as a vaccine preservative.
    Wkly Epidemiol Rec; 2000 Jan; 75(2):12-6. PubMed ID: 10697462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiomersal in vaccines: is removal warranted?
    Clements CJ; Ball LK; Ball R; Pratt RD
    Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.